The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the 99% stenosed, heavily tortuous, and heavily calcified anatomy resulting in the reported failure to advance and the reported difficult to remove.The reported material too soft/flexible (support of the sds was inferior to the non-abbott sds) is an opinion of the physician and not a quality issue with respect to manufacture, design or labeling with the product.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that the procedure was performed to treat a 99% stenosed, heavily tortuous, and heavily calcified concentric lesion in the posterior lateral artery.A 2.25x15mm xience skypoint stent delivery system (sds) was being advanced with a guide catheter extension; however, the sds failed to cross due to resistance with the anatomy.The sds was removed but resistance with the anatomy was noted.The procedure was successfully completed with a non-abbott stent.The physician commented that the deliverability/support of the xience skypoint was inferior to the non-abbott sds.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|